Title | Lead Author | Status | |
Previous and Subsequent Diagnosis in CIDP & Heredofamilial Amyloidosis with Regional Variations in England: HES Analysis | Monja Stein |
Finished Version
| View |
Plasma neurofilament light chain as a reliable biomarker of hereditary ATTR amyloidosis - A Swiss reference center experience | Valentin Loser |
Finished Version
| View |
Novel Homozygous COA8 Variant Leads to Cytochrome c Oxidase Deficiency Mimicking a Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Sean Freeman |
Finished Version
| View |
Creation of a preliminary POEMS-specific RODS using the UK POEMS cohort | Ryan YS Keh |
Finished Version
| View |
Anti-AGO1 antibodies identify a subgroup of sensory neuronopathy responding better to immunomodulatory treatment | Christian P. Moritz |
Finished Version
| View |
The antibody repertoire of inflammatory sensory neuronopathies targets pathways of the innate and adaptative immune system. | Christian P. Moritz |
Finished Version
| View |
Phenotype and molecular diagnostic yield in SMN1-negative Spinal Muscular Atrophy | Gorka Fernández-Eulate |
Finished Version
| View |
Not just a ‘bag-of-worms’: Subclinical electrodiagnostic markers as a useful tool in the identification, and monitoring, of Peripheral Nerve Hyperexcitability. | Nonnie McNicholas |
Finished Version
| View |
A relatively common cause of hereditary motor neuropathy due to a founder mutation in VWA1 | Sara Nagy |
Finished Version
| View |
Response to intravenous immunoglobulin in anti-FGFR3 positive sensory neuronopathy | Akin Nihat |
Finished Version
| View |
Monitoring of dysautonomia in Guillain-Barré syndrome: A multicentre retrospective cohort study | Syed Shehroz Ul Huda |
Finished Version
| View |
A fascinating case | Niall Doherty |
Finished Version
| View |
Demyelinating neuropathy with sub-acute, upper limb onset | Christopher J Record |
Finished Version
| View |
High prevalence of large fibre neuropathy following recreational nitrous oxide use: the Queen’s Hospital, BHRUT experience | Akin Nihat |
Finished Version
| View |
Rasch analysis of the Fatigue Severity Scale (FSS) and the Unidimensional Self-Efficacy (USE) Scale in Neuromuscular Disorders and comparison between sex, age and diagnoses | Josh Fulton |
Finished Version
| View |
Anti-MAG IgG antibodies occur and matter in anti-MAG neuropathy | Emilien Delmont |
Finished Version
| View |
Neurogenic involvement in COL6 mutated patients | Nur Villar-Quiles |
Finished Version
| View |
Updates on RFC1 disease: novel insights into the phenotypic and genotypic spectrum | Riccardo Curro |
Finished Version
| View |
Mycophenolate maintenance in CIDP facilitates reduction in IVIg dose and improvement in outcome measures | Amar Elsaddig |
Finished Version
| View |
Contribution of nerve biopsy in the diagnosis of peripheral neuropathies associated with lymphoid hemopathies: a retrospective analysis of 97 cases. | Louise Bicart-Sée |
Finished Version
| View |
Neurological and cardiac assessment of 130 TTR gene mutation carriers: a retrospective monocentric study | Diane Beauvais |
Finished Version
| View |
Immune mediated peripheral neuropathies: first results of the real-life data collection platform NEUROQUALI | Jean-Philippe Plançon |
Finished Version
| View |
Guillain-Barré syndrome in patients with CMT1a: an unpredictable course | Loïc Sellier Montaigne |
Finished Version
| View |